Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Read More 3 minute read Chemical Industry News Dow’s Texas plant disaster forces $500m revenue slash; Market confidence plummets Dow Inc. has stunned investors by slashing its third-quarter 2024 revenue forecast by a staggering $500 million due… byPallavi MadhirajuSeptember 12, 2024